Turnitin
降AI改写
早检测系统
早降重系统
Turnitin-UK版
万方检测-期刊版
维普编辑部版
Grammarly检测
Paperpass检测
checkpass检测
PaperYY检测
Oesophageal cancer
Oesophageal cancer is the sixth most common cause of cancer-related death worldwide
and is therefore a major global health challenge. The two major subtypes of oesophageal …
and is therefore a major global health challenge. The two major subtypes of oesophageal …
Improving outcomes in patients with oesophageal cancer
The care of patients with oesophageal cancer or of individuals who have an elevated risk of
oesophageal cancer has changed dramatically. The epidemiology of squamous cell and …
oesophageal cancer has changed dramatically. The epidemiology of squamous cell and …
Oesophageal cancer
Oesophageal cancer is a clinically challenging disease that requires a multidisciplinary
approach. Extensive treatment might be associated with a considerable decline in health …
approach. Extensive treatment might be associated with a considerable decline in health …
Advances in the curative management of oesophageal cancer
The incidence of oesophageal cancer, in particular adenocarcinoma, has markedly
increased over the last four decades with adenocarcinoma becoming the dominant subtype …
increased over the last four decades with adenocarcinoma becoming the dominant subtype …
Intratumor heterogeneity characterized by textural features on baseline 18F-FDG PET images predicts response to concomitant radiochemotherapy in esophageal …
18F-FDG PET is often used in clinical routine for diagnosis, staging, and response to therapy
assessment or prediction. The standardized uptake value (SUV) in the primary or regional …
assessment or prediction. The standardized uptake value (SUV) in the primary or regional …
Long-term results of a randomized trial of surgery with or without preoperative chemotherapy in esophageal cancer
WH Allum, SP Stenning, J Bancewicz… - Journal of clinical …, 2009 - ascopubs.org
Purpose OEO2 is a randomized, controlled trial of preoperative chemotherapy in patients
undergoing radical surgery for esophageal cancer. Random assignment was to surgery …
undergoing radical surgery for esophageal cancer. Random assignment was to surgery …
Cancer stem cell‐platelet hybrid membrane‐coated magnetic nanoparticles for enhanced photothermal therapy of head and neck squamous cell carcinoma
Cell membrane–based nanosystems with desirable characteristics have been studied
extensively for many therapeutic applications. However, current research has focused on …
extensively for many therapeutic applications. However, current research has focused on …
Myeloid‐derived suppressor cell membrane‐coated magnetic nanoparticles for cancer theranostics by inducing macrophage polarization and synergizing …
A major challenge for traditional cancer therapy, including surgical resection,
chemoradiotherapy, and immunotherapy, is how to induce tumor cell death and leverage the …
chemoradiotherapy, and immunotherapy, is how to induce tumor cell death and leverage the …
Randomized phase II study of pet response–adapted combined modality therapy for esophageal cancer: mature results of the CALGB 80803 (Alliance) trial
PURPOSE To evaluate the use of early assessment of chemotherapy responsiveness by
positron emission tomography (PET) imaging to tailor therapy in patients with esophageal …
positron emission tomography (PET) imaging to tailor therapy in patients with esophageal …
PET to assess early metabolic response and to guide treatment of adenocarcinoma of the oesophagogastric junction: the MUNICON phase II trial
Background In patients with locally advanced adenocarcinoma of the oesophagogastric
junction (AEG), early metabolic response defined by 18-fluorodeoxyglucose-PET ([18 F] …
junction (AEG), early metabolic response defined by 18-fluorodeoxyglucose-PET ([18 F] …